Should I Buy Alexandria Real Estate (ARE)? Finance YouTuber Analysis

The YouTuber made a follow-up purchase of Alexandria Real Estate Equities, a premium REIT focused on labs and biopharma. Despite current challenges in the biopharma sector, he believes the company will navigate them without a dividend cut, noting its current dividend yield of almost 7%.

“Die Dividendenite liegt hierbei momentan äh fast 7 % mittlerweile 6,9 % tatsächlich habe ich jetzt ein Nachkauf gemacht und zwar habe ich die Aktie nachgekauft am 21.04 vierten jetzt.”

The YouTuber identifies Alexandria Real Estate Equity as a REIT with a high dividend yield (6.5%) due to recent price drops. He notes its stable business model based on long-term leases for lab campuses to large biotech/pharma companies, providing security in uncertain times. He plans to buy if the price falls below $850.

“Alexandria Real Estate Equity. Hier seht ihr mein Nachkaufslimit. Das wurde schon deutlich unterschritten. Aktuelle Dividendredite 6,5%.”

The YouTuber has bought more shares of Alexandria Real Estate Equities, citing its current high dividend yield and significant price drop from its peak as a buying opportunity. Despite headwinds in the biotech sector, the company maintains a high occupancy rate and its dividend appears secure based on adjusted funds from operations. The stock is trading at a historically low FFO multiple, suggesting undervaluation with potential for double-digit annual returns if the stock recovers to even modest levels.

“wenn du glaubst dass Alexandria real estate gut aufgestellt ist und kein Problem damit hat eine Durststrecke die auch noch ein bisschen länger anhalten kann zu überstehen im Bereich Biotechnologie bevor es man wieder runter läuft und dann auch die Leerstandsquote sukzessive weiter abgebaut wird und FFO nach oben geht dann wäre auch die Aktie für dich interessant”

The YouTuber mentions Alexandria Real Estate for its 4.4% dividend and unique position in healthcare REITs. The company specializes in life science laboratories and has a venture unit, providing a growth kicker not typically seen in other REITs.

“The company owns 350 properties almost exclusively life science Laboratories leased out to research and testing but it also has a venture unit investing in the industry so that growth kicker That You Don't See with most other reats”